
Axsome Therapeutics: Stock Soars 20% Following Patent Settlement with Teva Pharmaceuticals in the Medical Sector
AXSM Stock Surges After Auvelity Patent Settlement with Teva In a significant development for the pharmaceutical industry, Axsome Therapeutics (AXSM) announced on March 1, 2023, that it had reached a patent litigation settlement with Teva Pharmaceuticals (TEVA) regarding the Auvelity drug. This settlement has led to a 20% surge in AXSM’s stock price. Details of…